• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

What’s that sound????

























yes “mega” company to destroy competition; however delve into FVC business plan and it is apparent the direction is ecommerce utilization to the Vet, as well as to pet owner’s, etailers and a plan to go head to head against Amazon. Days of Burns/Butler/Schein FIELD Reps are coming to an end.
 






It's the sound of the giant sucking up everything in its path and spitting out the pieces it doesn't want. It's too big to fail. The 1% grows. Bye Bye Merritt, Vets First Choice and anyone that turned a profit or had customers that represented sales not being made thru a Schein company...